Who Paid My Doc
Scott Marlowe
Diagnostic Ultrasound Lewistown, PA Medical Doctor
NPI 1326021700 CMS profile 771119
400 Highland Ave, Lewistown, PA 17044
General payments
$170
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Scott Marlowe of Lewistown, PA is reported in the CMS Open Payments database as having received $170 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $154 | 3 | |
| 2019 | General | $16 | 1 |
Beside peers
- Scott Marlowe
- Diagnostic Ultrasound median
- Middle half of Diagnostic Ultrasound
- National median
In program year 2025, general payments to Scott Marlowe were reported at $0. Among 21 Diagnostic Ultrasound profiles paid that year, the median was $96 and the middle half received between $28 and $176.
Show as a table
| Year | Scott Marlowe | Diagnostic Ultrasound median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $16 | $62 | $16–$172 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $58 | $16–$248 | $132 |
| 2022 | $0 | $92 | $24–$166 | $149 |
| 2023 | $0 | $65 | $20–$123 | $160 |
| 2024 | $154 | $91 | $24–$274 | $164 |
| 2025 | $0 | $96 | $28–$176 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
17
Drug cost
$368
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | Brand | 17 | $368 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 150 billing codesPaid by Medicare
$336,624
Medicare patients
4,622
Services billed
12,675
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 60% | |
| Ischemic heart disease | 44% | |
| Chronic kidney disease | 31% | |
| Depression | 30% | |
| Atrial fibrillation | 29% | |
| Diabetes | 28% | |
| COPD | 25% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, gadopiclenol, 1 ml A9573 | Office | 73 | 680 | $2,518 |
| Injection, gadobenate dimeglumine (multihance), per ml A9577 | Office | 29 | 580 | $836 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml A9579 | Office | 29 | 510 | $606 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 60 | 4,270 | $435 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Ultrasound in Pennsylvania
Related records
Diagnostic Ultrasound in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Ultrasound
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.